Estimation of selected parameters antioxidant barrier and lipid parameters in children with atherosclerosis risk factors;Ocena wy br anych parametrów bariery antyoksydacyjnej i przemiany lipidowej u dzieci ze stwierdzonymi czynnikami ryzyka miażdżycy

Polski Merkuriusz Lekarski

Volumn 24, Issue 139, 2008, Pages 14-17

  Sierakowska Fijalek, Anna ^a   FijaŁkowski, Pawel ^a   Blaszczyk, Jan ^a   Baj, Zbigniew ^a   Stȩpien, Mariusz ^a   Wosik Erenbek, Marzenna ^a   Rysz, Jacek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Antioxidants; Atherosclerosis; Children; Lipid levels

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CATALASE; CHOLESTEROL; GLUTATHIONE PEROXIDASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; ATHEROSCLEROSIS; BLOOD; COMORBIDITY; DYSLIPIDEMIA; EPIDEMIOLOGY; FEMALE; HUMAN; HYPERTENSION; LIPID METABOLISM; MALE; METABOLISM; OBESITY; RISK FACTOR;

ADOLESCENT; ANTIOXIDANTS; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CATALASE; CAUSALITY; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COMORBIDITY; DYSLIPIDEMIAS; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; HYPERTENSION; LIPID METABOLISM; MALE; MALONDIALDEHYDE; OBESITY; REACTIVE OXYGEN SPECIES; RISK FACTORS; SUPEROXIDE DISMUTASE; TRIGLYCERIDES;

EID: 39049118806     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Beers R., Sizer T.: Spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem., 1952, 195, 133-140.
2. Berenson G.S.: Childhood risk factors predict adult risk associated with subclinical cardiovascular disease. The Bogalusa Heart Study. Am. J. Cardiol., 2002, 21, 90, 3L-7L.
3. Cal H., Harrison D.G.: Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ. Res., 2000, 87, 840-844.
4. Collins T.: Biology and disease. Endothelial nuclear factor-B and the iniciation of the atherosclerotic lesion. Lab. Invest., 1993, 68, 499-508.
5. Comhair S.A., Erzurun S.C.: The regulation and role of extracellular glutathione peroxidase. Antioxid. Redox. Signal., 2005, 7, 72-79.
6. Ehara S., Ueda M., Naruko T. i wsp.: Elevated levels of oxidized lowdensity lipoprotein show a positive relationship with the severity of acute coronary syndromes. Circulation, 2001, 103, 19-55.
7. Gruber B.: Enzymy chroniace organizm przed aktywnymi formami tlenu. Farm. Pol., 1996, 67, 11/12, 750-756.
8. Guemouri L., Artur Y., Herbeth B. i wsp.: Biological variability of superoxide dismutase, glutathione peroxidase and catalase in blood. Clin. Chem., 1991, 37, 1932-1937.
9. Hapyn E., Czerwionka-Szaflarska M., Drewa G.: Enzymatic efficiency of erythrocyte antioxidant barrier and lipid peroxidation in children from families with high risk of early atherosclerosis. Med. Sci. Monit., 2000, 6(1), 112-116.
10. Heitzer T., Yla-Herttuala S., Luoma J. i wsp.: Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized IdI. Circulation, 1996, 93, 1346-1353.
11. Khan B.V., Pathasarathy S.S., Alexander R.W. i wsp.: Modifield low-density lipoprotein and its constituents augment cytokine activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest., 1995, 95, 1265-1270.
12. Kowalski J., Btaszczyk J., Olejniczak J. i wsp.: Wpływ fluwastatyny i fenofibratu na wytwarzanie reaktywnych form tlenu i peroksydacjȩ lipidów u chorych z dyslipidemia̧_. Pol. Merk. Lek., 2003, 14, 279-283.
13. Kulikowska-Karpmska E., Moniuszko-Jakoniuk J.: The antioxidant barrier in the organism. Pol. J. Environ. Stud., 2004, 13, 5-13.
14. Kume N., Cybulsky M.l., Gimbrone Jr. M.A.: Lysophosphatidilecholine a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest., 1992, 90, 1138-1144.
15. Little C.O., Brien P.: Intracellular GSH-peroxidase with a lipid peroxide substrate. Biophys. Res. Commun., 1968, 31, 145-150.
16. McGill H. Jr., Mc. Mahan A., Herderich E. i wsp.: Origin of atherosclerosis in childhood and adolescence. Am. J. of Clin. Nutr., 2000, 72, 5, 1307-1315.
17. McGill H. Jr., McMahan A., Herderich E. i wsp.: Origin of atherosclerosis in childhood and adolescence. Am. J. Clin. Nutr., 2000, 72, 5, 1307-1315.
18. Misra H.P., Fridovich J.: The role of superoxide anion in the autooxidation of epinephrine and a simple assey superoxide dismutase. J. Biol. Chem., 1992, 247, 3170-3173.
19. Navab M., Hama S.Y., Nguyen T.B., Fogelman A.M.: Monocyte adhesion and transmigration in atherosclerosis. Coron. Artery Dis., 1994, 5, 198-204.
20. Placer Z., Cushman L., Jonson B.: Estimation of product of lipid peroxidation malonylodialdehyde in biochemical systems. Ann. Bioch., 1966, 16, 359-364.
21. Raven P.D., Witzum J.L.: Oxidized low density lipiproteins in atherogenesis: role of dietary modyfcation. Ann. Rev. Nutr., 1996, 16, 51-61.
22. Ross R.: Cell biology of atherosclerosis. Ann. Rev. Physiol., 1995, 57, 791-804.
23. Schnackenberg C.G.: Oxigen radicals in cardiovascular-renal disease. Curr. Opin. Pharmacol., 2002, 2, 121,
24. Sedlak J., Lindsay A.: Estimation of total protein bound and nonprotein sulhydryl groups tissue with Ellmans reagent. Anal. Biochem., 1968, 26, 192-205.
25. Selvyn A.P., Kinlay S., Libby P. i wsp.: Atherogenic lipids, vascular dysfunction and clinical signs of ischemic heart disease. Circulation, 1997, 95, 5-7.
26. Sies H.: Oxidative stress: oxidants and antioxidants. Exp. Physiol., 1997, 82, 291-295.
27. Ścibior D., Czeczot H.: Kataliza - budowa, właś ciwości, funkcje. Postçpy Hig. Med. Dośw., 2006, 60, 170-180.
28. Vanhoutte P.M.: Endothelial dysfunction and atherosclerosis. Eur. Heart J., 1997, 18 supl. E, 19-29.
29. Wielkoszyński T., Jagodzińska J.: Udział procesów peroksydacji lipidów w patogenezie nadciśnienia pierwotnego i indukowanego ciȧ̧a̧_. Czyn. Ryz., 2001, 3-4, 29-34.
30. Włodarska M., Gawor Z., Piotrowski G. i wsp.: Ocena czynników ryzyka choroby niedokrwiennej serca u studentów Politechniki Czȩstochowskiej z otyłościa̧ i nadwaga̧. Czyn. Ryz., 2004, 1-2, 23-31.
31. Yesilbursa D., Serdar Z., Serdar A. i wsp.: Lipid peroxidation in obese patients and effect of weight loss with orlistat on lipid peroxides levels. Internat. J. Obes., 2005, 29, 142-145.
32. Zapolska-Downar D.: Dysfunkcja komórek śró dbłonka jako jeden z czynników patogenetycznych miażḋycy. Normalizujácy wplyw niektórych leków. Czyn. Ryz., 2000, 4, 5-15.
33. Ziemlański S., Wartanowicz M.: Rola antyoksydantów źywieniowych w stanie zdrowia i choroby. Ped. Wsp. Gastr., Hepa, i Żyw. Dziecka, 1999, 1, 2/3, 97-105.